Aurora Cannabis Inc. (ACB)

Theseus Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	140.16	137.92	136.1	234.94	437.81	421.46
Short-Term Investments	-	0.55	4.04	-	1.33	3.75
Cash & Short-Term Investments	140.16	138.48	140.13	234.94	439.14	425.21
Cash Growth	21.36%	-1.18%	-40.36%	-46.50%	3.28%	151.24%
Accounts Receivable	39.14	36.6	43	37.11	30.55	43.01
Other Receivables	-	5.87	2.41	4.24	16.5	13.47
Receivables	39.14	42.47	45.41	41.35	47.05	56.48
Inventory	228.26	239.09	186.38	128.82	139.93	137.72
Prepaid Expenses	11.66	10.66	9.4	8.28	6.54	11.17
Restricted Cash	45.87	47.41	43.13	65.9	50.97	19.39
Other Current Assets	0.21	0.22	2.16	0.64	61.5	15.92
Total Current Assets	465.3	478.33	426.61	479.93	745.12	665.89
Property, Plant & Equipment	266.21	266.91	293.13	321.25	230.3	598.28
Long-Term Investments	-	-	-	-	1.21	0.29
Goodwill	43.69	43.87	43.18	18.72	-	887.74
Other Intangible Assets	47.1	46.36	42.05	61.4	73.86	375.26
Long-Term Accounts Receivable	4.87	5.26	6.34	6.5	4.43	4.26
Long-Term Deferred Tax Assets	4.16	4.22	15.34	15.5	-	-
Other Long-Term Assets	6.51	7.72	12.03	23.04	29.43	62.92
Total Assets	837.84	852.67	838.67	926.32	1,084	2,605
Accounts Payable	81.29	27.62	20.33	21.94	13.86	13.28
Accrued Expenses	-	45.96	38.09	48.83	54.62	43.8
Current Portion of Long-Term Debt	59.84	21.51	52.36	142.14	26.85	34.75
Current Portion of Leases	5.49	5.38	4.86	5.41	6.15	6.19
Current Income Taxes Payable	6.89	7.6	1.55	0.16	0.17	-
Current Unearned Revenue	1.69	1.07	1.69	14.14	16.25	4.17
Other Current Liabilities	1.69	1.72	5.75	5.11	12.96	14.19
Total Current Liabilities	156.89	110.86	124.62	237.74	130.86	116.38
Long-Term Debt	-	40.19	4.9	36.16	199.65	293.18
Long-Term Leases	36.3	37.5	42.68	43.8	36.84	65.43
Long-Term Deferred Tax Liabilities	1.92	1.9	16.19	16.75	2.86	-
Other Long-Term Liabilities	54.05	53.63	48.42	70.17	51.8	92.04
Total Liabilities	249.16	244.08	236.8	404.62	422	567.03
Common Stock	6,991	6,991	6,971	6,841	6,755	6,424
Retained Earnings	-6,384	-6,368	-6,368	-6,292	-6,038	-4,321
Comprehensive Income & Other	-215.89	-56.24	-43.71	-58.33	-54.51	-65.51
Total Common Equity	551.92	567.17	559.77	490.64	661.84	2,038
Minority Interest	36.76	41.42	42.1	31.06	0.51	-
Shareholders' Equity	588.68	608.59	601.87	521.71	662.35	2,038
Total Liabilities & Equity	837.84	852.67	838.67	926.32	1,084	2,605
Total Debt	101.63	104.58	104.79	227.52	269.49	399.55
Net Cash (Debt)	38.53	33.89	35.34	7.42	169.65	25.66
Net Cash Growth	187.91%	-4.10%	376.28%	-95.63%	561.19%	-
Net Cash Per Share	0.69	0.61	0.82	0.24	7.89	1.52
Filing Date Shares Outstanding	56.45	56.23	54.55	35.42	30.04	19.81
Total Common Shares Outstanding	56.25	56.23	54.55	34.53	29.78	19.81
Working Capital	308.42	367.47	301.99	242.19	614.26	549.52
Book Value Per Share	9.81	10.09	10.26	14.21	22.23	102.88
Tangible Book Value	461.14	476.94	474.55	410.53	587.99	774.7
Tangible Book Value Per Share	8.20	8.48	8.70	11.89	19.75	39.11
Land	-	43.94	43.91	50.26	13.13	23.98
Buildings	-	242.94	241.75	235.51	172.81	-
Machinery	-	159.89	161.74	152.67	155.25	185.16
Construction In Progress	-	27.15	25.69	25.62	25.09	77.64

Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q